Literature DB >> 29248138

Pathophysiology of AKI.

Marlies Ostermann1, Kathleen Liu2.   

Abstract

Acute kidney injury (AKI) is common in the perioperative and intensive care setting. Although AKI is usually multifactorial, haemodynamic instability, sepsis and drug toxicity are commonly implicated. Independent of the exact aetiology, several different pathophysiologic processes occur simultaneously and in sequence, including endothelial dysfunction, alteration of the microcirculation, tubular injury, venous congestion and intrarenal inflammation. A multitude of different immune cells from within the kidney and the systemic circulation play a role in the development, maintenance and recovery phase of AKI. In this review, we describe the common processes involved in AKI and their connections, with particular emphasis on the perioperative and critical care setting.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  acute kidney injury; endothelial dysfunction; inflammation; microcirculation; pathophysiology; tubular injury

Mesh:

Year:  2017        PMID: 29248138     DOI: 10.1016/j.bpa.2017.09.001

Source DB:  PubMed          Journal:  Best Pract Res Clin Anaesthesiol        ISSN: 1521-6896


  25 in total

1.  Current Status of Novel Biomarkers for the Diagnosis of Acute Kidney Injury: A Historical Perspective.

Authors:  Benjamin R Griffin; Katja M Gist; Sarah Faubel
Journal:  J Intensive Care Med       Date:  2019-01-17       Impact factor: 3.510

2.  The IRE1/JNK signaling pathway regulates inflammation cytokines and production of glomerular extracellular matrix in the acute kidney injury to chronic kidney disease transition.

Authors:  Yan Liang; Lingyun Qu; Zhenjie Liu; Lulu Liang; Yingzi Wang; Songxia Quan; Yulin Wang; Lin Tang
Journal:  Mol Biol Rep       Date:  2022-06-13       Impact factor: 2.742

3.  circSTRN3 aggravates sepsis-induced acute kidney injury by regulating miR-578/ toll like receptor 4 axis.

Authors:  Qiuying Gao; Yan Zheng; Hui Wang; Limin Hou; Xingxing Hu
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

4.  Selective abdominal venous congestion to investigate cardiorenal interactions in a rat model.

Authors:  Jirka Cops; Wilfried Mullens; Frederik H Verbrugge; Quirine Swennen; Carmen Reynders; Joris Penders; Jean-Michel Rigo; Dominique Hansen
Journal:  PLoS One       Date:  2018-05-29       Impact factor: 3.240

Review 5.  Biomarker-Guided Risk Assessment for Acute Kidney Injury: Time for Clinical Implementation?

Authors:  Christian Albert; Michael Haase; Annemarie Albert; Antonia Zapf; Rüdiger Christian Braun-Dullaeus; Anja Haase-Fielitz
Journal:  Ann Lab Med       Date:  2020-08-25       Impact factor: 3.464

6.  Acute kidney injury and 1-year mortality after colorectal cancer surgery: a population-based cohort study.

Authors:  Charlotte Slagelse; Henrik Gammelager; Lene Hjerrild Iversen; Henrik Toft Sørensen; Christian F Christiansen
Journal:  BMJ Open       Date:  2019-03-13       Impact factor: 2.692

7.  Circular RNA YAP1 acts as the sponge of microRNA-21-5p to secure HK-2 cells from ischaemia/reperfusion-induced injury.

Authors:  Tao Huang; Yanwei Cao; Hongyang Wang; Qinghai Wang; Jianlei Ji; Xiaoxia Sun; Zhen Dong
Journal:  J Cell Mol Med       Date:  2020-03-11       Impact factor: 5.310

8.  The impact of mild renal dysfunction on isolated cardiopulmonary coronary artery bypass grafting: a retrospective propensity score matching analysis.

Authors:  Xian Wang; Yifan Zhu; Wen Chen; Liangpeng Li; Xin Chen; Rui Wang
Journal:  J Cardiothorac Surg       Date:  2019-11-07       Impact factor: 1.637

9.  Epidemiology and the Impact of Acute Kidney Injury on Outcomes in Patients with Rhabdomyolysis.

Authors:  Chien-Wen Yang; Si Li; Yishan Dong; Nitpriya Paliwal; Yichen Wang
Journal:  J Clin Med       Date:  2021-05-01       Impact factor: 4.241

Review 10.  Complete blood count in acute kidney injury prediction: a narrative review.

Authors:  Joana Gameiro; José António Lopes
Journal:  Ann Intensive Care       Date:  2019-08-06       Impact factor: 6.925

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.